News

Dermata to Present at the H.C. Wainwright Global Investment Conference

SAN DIEGO, CA / ACCESSWIRE / May 23, 2022 / Dermata Therapeutics, Inc. (NASDAQ:DRMA) ("Dermata" or the "Company"), a clinical-stage…

2 years ago

Endocanna Health Enters into an Agreement with We Decode and America’s Combat Nurse to Help Veterans Obtain Personalized Safe Cannabis

BURBANK, CA / ACCESSWIRE / May 23, 2022 / Endocanna Health, the industry leader in endocannabinoid system genomic testing, has…

2 years ago

Altamira Therapeutics Receives Philippines’ FDA Approval of Bentrio Nasal Spray

HAMILTON, BERMUDA / ACCESSWIRE / May 23, 2022 / Altamira Therapeutics Ltd. (NASDAQ:CYTO), a company dedicated to developing therapeutics that…

2 years ago

Pioneering UK Start-up Participates in AWS Summit Washington, DC to Showcase Value of AI Patient Listening Tool to US Market

WASHINGTON, DC / ACCESSWIRE / May 23, 2022 / UK-based health technology company PEP Health will today (Monday 23rd May…

2 years ago

Biotricity to Present at the 2022 H.C. Wainwright Global Investment Conference on Tuesday May 24th

REDWOOD CITY, CA / ACCESSWIRE / May 23, 2022 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic…

2 years ago

Jaguar Health Announces Launch of the First U.S. Canine Cancer Registry and Canine Cancer Care Index

"Canine Cancer: Take C.H.A.R.G.E." (Canine Health And ReGistry Exchange) Based on Nationwide Gallup Poll of Pet Owners and Initial Assessment…

2 years ago

Ceapro Inc. to Present at the H.C. Wainwright Global Investment Conference

EDMONTON, Alberta, May 23, 2022 (GLOBE NEWSWIRE) -- Ceapro Inc.  (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage…

2 years ago

Praxis Precision Medicines Adds Global Business Expertise to Board of Directors with Appointment of Jill DeSimone

BOSTON, May 23, 2022 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights…

2 years ago

Revelation Biosciences Inc. Announces Safety Monitoring Committee Recommendation for Continuing Evaluation of REVTx-99b for the Treatment of Allergic Rhinitis

Top-line data anticipated in the Q3 2022SAN DIEGO, May 23, 2022 (GLOBE NEWSWIRE) -- Revelation Biosciences Inc. (NASDAQ: REVB) (the…

2 years ago

Sientra To Present At The William Blair 42nd Annual Growth Stock Conference

SANTA BARBARA, Calif., May 23, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), announced today its…

2 years ago